Reversal of signs and symptoms of a B-Cell lymphoma in a patient using only low-dose naltrexone

被引：12

作者：

Berkson, Burton M. ^{[1
]}

Rubin, Daniel M. ^{[1
]}

Berkson, Arthur J. ^{[1
]}

机构：

[1] Integrat Med Ctr New Mexico, Las Cruces, NM USA

来源：

INTEGRATIVE CANCER THERAPIES | 2007年 / 6卷 / 03期

关键词：

D O I：

10.1177/1534735407306358

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：293 / 296

页数：4

共 14 条

[1] The long-term survival of a patient with pancreatic cancer with metastases to the liver after treatment with the intravenous α-lipoic acid/low-dose naltrexone protocol [J].

Berkson, Burton M. ;

Rubin, Daniel M. ;

Berkson, Arthur J. .

INTEGRATIVE CANCER THERAPIES, 2006, 5 (01) :83-89

[2]

BIHARI B, 1995, AIDS PATIENT CARE, V9, P3, DOI 10.1089/apc.1995.9.3

[3]

BIHARI B, LDN CANC LOW DOSE NA

[4]

FREEDMAN AS, CLIN PATHOLOGIC FEAT

[5] Non-Hodgkin lymphoma: an update [J].

Hennessy, BT ;

Hanrahan, E ;

Daly, PA .

LANCET ONCOLOGY, 2004, 5 (06) :341-353

[6] ENKEPHALINS, BRAIN AND IMMUNITY - MODULATION OF IMMUNE-RESPONSES BY METHIONINE-ENKEPHALIN INJECTED INTO THE CEREBRAL CAVITY [J].

JANKOVIC, BD ;

RADULOVIC, J .

INTERNATIONAL JOURNAL OF NEUROSCIENCE, 1992, 67 (1-4) :241-270

[7] RADIOENDOCRINE THERAPY OF BRAIN-TUMORS WITH THE LONG-ACTING OPIOID ANTAGONIST NALTREXONE IN ASSOCIATION WITH RADIOTHERAPY [J].

LISSONI, P ;

MEREGALLI, S ;

FOSSATI, V ;

BARNI, S ;

TANCINI, G ;

BARIGOZZI, P ;

FRIGERIO, F .

TUMORI, 1993, 79 (03) :198-201

[8]

MATHEWS PM, 1983, J IMMUNOL, V130, P1658

[9]

Ott OJ, 2003, STRAHLENTHER ONKOL, V179, P694, DOI 10.1007/s00066-003-1062-8

[10]

SINGLETON PA, MICROVASC RES, V6, P72

← 1 2 →